{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:07:27Z","timestamp":1761394047441},"reference-count":48,"publisher":"China Science Publishing & Media Ltd.","issue":"6","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2011,6,1]]},"DOI":"10.1093\/abbs\/gmr032","type":"journal-article","created":{"date-parts":[[2011,5,31]],"date-time":"2011-05-31T15:31:00Z","timestamp":1306855860000},"page":"487-495","update-policy":"http:\/\/dx.doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":26,"title":["Histone deacetylase inhibitor valproic acid sensitizes B16F10 melanoma cells to cucurbitacin B treatment"],"prefix":"10.3724","volume":"43","author":[{"given":"Dongyun","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingbing","family":"Zha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianhui","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2026","published-online":{"date-parts":[[2011,6,1]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.2146\/ajhp080460","volume":"65","author":"Trinh VA","year":"2008","unstructured":"Trinh VA. Current management of metastatic melanoma. Am J Health Syst Pharm, 2008, 65: S3-S8.","journal-title":"Am J Health Syst Pharm"},{"key":"null","first-page":"1270","volume":"63","author":"Blaskovich MA","year":"2003","unstructured":"Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R, Sebti SM. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase\/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res, 2003, 63: 1270-1279.","journal-title":"Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1349-7006.2008.00899.x","volume":"99","author":"Wakimoto N","year":"2008","unstructured":"Wakimoto N, Yin D, O'Kelly J, Haritunians T, Karlan B, Said J, Xing H. Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo. Cancer Sci, 2008, 99: 1793-1797.","journal-title":"Cancer Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/ijc.23648","volume":"123","author":"Yin D","year":"2008","unstructured":"Yin D, Wakimoto N, Xing H, Lu D, Huynh T, Wang X, Black KL. Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme. Int J Cancer, 2008, 123: 1364-1375.","journal-title":"Int J Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.leukres.2008.01.019","volume":"32","author":"Haritunians T","year":"2008","unstructured":"Haritunians T, Gueller S, Zhang L, Badr R, Yin D, Xing H, Fung MC. Cucurbitacin B induces differentiation, cell cycle arrest, and actin cytoskeletal alterations in myeloid leukemia cells. Leuk Res, 2008, 32: 1366-1373.","journal-title":"Leuk Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/MPA.0b013e3181ce719e","volume":"39","author":"Zhang M","year":"2010","unstructured":"Zhang M, Sun C, Shan X, Yang X, Li-Ling J, Deng Y. Inhibition of pancreatic cancer cell growth by cucurbitacin B through modulation of signal transducer and activator of transcription 3 signaling. Pancreas, 2010, 39: 923-929.","journal-title":"Pancreas"},{"key":"null","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00405-008-0625-9","volume":"265","author":"Liu T","year":"2008","unstructured":"Liu T, Zhang M, Zhang H, Sun C, Deng Y. Inhibitory effects of cucurbitacin B on laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol, 2008, 265: 1225-1232.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"null","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/mnfr.200900165","volume":"54","author":"Yasuda S","year":"2010","unstructured":"Yasuda S, Yogosawa S, Izutani Y, Nakamura Y, Watanabe H, Sakai T. Cucurbitacin B induces G2 arrest and apoptosis via a reactive oxygen species-dependent mechanism in human colon adenocarcinoma SW480 cells. Mol Nutr Food Res, 2010, 54: 559-565.","journal-title":"Mol Nutr Food Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.canlet.2010.01.029","volume":"294","author":"Chan KT","year":"2010","unstructured":"Chan KT, Meng FY, Li Q, Ho CY, Lam TS, To Y, Lee WH. Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration. Cancer Lett, 2010, 294: 118-124.","journal-title":"Cancer Lett"},{"key":"null","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1074-7613(00)80011-4","volume":"10","author":"Catlett-Falcone R","year":"1999","unstructured":"Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity, 1999, 10: 105-115.","journal-title":"Immunity"},{"key":"null","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02258360","volume":"5","author":"Garcia R","year":"1998","unstructured":"Garcia R, Jove R. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J Biomed Sci, 1998, 5: 79-85.","journal-title":"J Biomed Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1196\/annals.1378.063","volume":"1091","author":"Aggarwal BB","year":"2006","unstructured":"Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, Sung B. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci, 2006, 1091: 151-169.","journal-title":"Ann N Y Acad Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"10014","DOI":"10.1073\/pnas.180316197","volume":"97","author":"Richon VM","year":"2000","unstructured":"Richon VM, Sandhoff TW, Rifkind RA, Marks PA. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci USA, 2000, 97: 10014-10019.","journal-title":"Proc Natl Acad Sci USA"},{"key":"null","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/86507","volume":"7","author":"Kim MS","year":"2001","unstructured":"Kim MS, Kwon HJ, Lee YM, Baek JH, Jang JE, Lee SW, Moon EJ. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med, 2001, 7: 437-443.","journal-title":"Nat Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4161\/cbt.8.9.8118","volume":"8","author":"Di GE","year":"2009","unstructured":"Di GE, Bruzzese F, Pepe S, Leone A, Delrio P, Subbarayan PR, Avallone A. Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or raltitrexed. Cancer Biol Ther, 2009, 8: 782-791.","journal-title":"Cancer Biol Ther"},{"key":"null","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00280-010-1287-z","volume":"67","author":"Wittenburg LA","year":"2011","unstructured":"Wittenburg LA, Bisson L, Rose BJ, Korch C, Thamm DH. The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin. Cancer Chemother Pharmacol, 2011, 67: 83-92.","journal-title":"Cancer Chemother Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.ejca.2010.03.021","volume":"46","author":"Hubaux R","year":"2010","unstructured":"Hubaux R, Vandermeers F, Crisanti MC, Kapoor V, Burny A, Mascaux C, Albelda SM. Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy. Eur J Cancer, 2010, 46: 1724-1734.","journal-title":"Eur J Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2009.10.011","volume":"625","author":"Kristensen LS","year":"2009","unstructured":"Kristensen LS, Nielsen HM, Hansen LL. Epigenetics and cancer treatment. Eur J Pharmacol, 2009, 625: 131-142.","journal-title":"Eur J Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1471-4159.2002.01081.x","volume":"83","author":"Bacon CL","year":"2002","unstructured":"Bacon CL, Gallagher HC, Haughey JC, Regan CM. Antiproliferative action of valproate is associated with aberrant expression and nuclear translocation of cyclin D3 during the C6 glioma G1 phase. J Neurochem, 2002, 83: 12-19.","journal-title":"J Neurochem"},{"key":"null","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.canlet.2009.03.013","volume":"280","author":"Batty N","year":"2009","unstructured":"Batty N, Malouf GG, Issa JP. Histone deacetylase inhibitors as anti-neoplastic agents. Cancer Lett, 2009, 280: 192-200.","journal-title":"Cancer Lett"},{"key":"null","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.canlet.2009.07.015","volume":"289","author":"Chan KT","year":"2010","unstructured":"Chan KT, Li K, Liu SL, Chu KH, Toh M, Xie WD. Cucurbitacin B inhibits STAT3 and the Raf\/MEK\/ERK pathway in leukemia cell line K562. Cancer Lett, 2010, 289: 46-52.","journal-title":"Cancer Lett"},{"key":"null","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"Phiel CJ","year":"2001","unstructured":"Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem, 2001, 276: 36734-36741.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","volume":"22","author":"Kramer OH","year":"2003","unstructured":"Kramer OH, Zhu P, Ostendorff HP, Golebiewski M, Tiefenbach J, Peters MA, Brill B. The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J, 2003, 22: 3411-3420.","journal-title":"EMBO J"},{"key":"null","first-page":"S91","volume":"83","author":"Gottlicher M","year":"2004","unstructured":"Gottlicher M. Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases. Ann Hematol, 2004, 83: S91-S92.","journal-title":"Ann Hematol"},{"key":"null","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1042\/BST0340007","volume":"34","author":"Wek RC","year":"2006","unstructured":"Wek RC, Jiang HY, Anthony TG. Coping with stress: eIF2 kinases and translational control. Biochem Soc Trans, 2006, 34: 7-11.","journal-title":"Biochem Soc Trans"},{"key":"null","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/sj.cdd.4401984","volume":"14","author":"Kouroku Y","year":"2007","unstructured":"Kouroku Y, Fujita E, Tanida I, Ueno T, Isoai A, Kumagai H, Ogawa S. ER stress (PERK\/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ, 2007, 14: 230-239.","journal-title":"Cell Death Differ"},{"key":"null","doi-asserted-by":"crossref","first-page":"18737","DOI":"10.1074\/jbc.M109.091694","volume":"285","author":"Karna P","year":"2010","unstructured":"Karna P, Zughaier S, Pannu V, Simmons R, Narayan S, Aneja R. Induction of reactive oxygen species-mediated autophagy by a novel microtubule-modulating agent. J Biol Chem, 2010, 285: 18737-18748.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11010-010-0638-8","volume":"348","author":"Eum KH","year":"2011","unstructured":"Eum KH, Lee M. Crosstalk between autophagy and apoptosis in the regulation of paclitaxel-induced cell death in v-Ha-ras-transformed fibroblasts. Mol Cell Biochem, 2011, 348: 61-68.","journal-title":"Mol Cell Biochem"},{"key":"null","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0960-9822(00)00610-2","volume":"10","author":"Paull TT","year":"2000","unstructured":"Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol, 2000, 10: 886-895.","journal-title":"Curr Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","volume":"273","author":"Rogakou EP","year":"1998","unstructured":"Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem, 1998, 273: 5858-5868.","journal-title":"J Biol Chem"},{"key":"null","first-page":"220","volume":"1806","author":"Chen S","year":"2010","unstructured":"Chen S, Rehman SK, Zhang W, Wen A, Yao L, Zhang J. Autophagy is a therapeutic target in anticancer drug resistance. Biochim Biophys Acta, 2010, 1806: 220-229.","journal-title":"Biochim Biophys Acta"},{"key":"null","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2010.04.062","volume":"641","author":"Liu T","year":"2010","unstructured":"Liu T, Peng H, Zhang M, Deng Y, Wu Z. Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin. Eur J Pharmacol, 2010, 641: 15-22.","journal-title":"Eur J Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1517\/13543784.2010.510514","volume":"19","author":"Marks PA","year":"2010","unstructured":"Marks PA. The clinical development of histone deacetylase inhibitors as targeted anticancer drugs. Expert Opin Investig Drugs, 2010, 19: 1049-1066.","journal-title":"Expert Opin Investig Drugs"},{"key":"null","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2119\/2007-00084.Bokelmann","volume":"14","author":"Bokelmann I","year":"2008","unstructured":"Bokelmann I, Mahlknecht U. Valproic acid sensitizes chronic lymphocytic leukemia cells to apoptosis and restores the balance between pro- and antiapoptotic proteins. Mol Med, 2008, 14: 20-27.","journal-title":"Mol Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2004.10.020","volume":"42","author":"Armeanu S","year":"2005","unstructured":"Armeanu S, Pathil A, Venturelli S, Mascagni P, Weiss TS, Gottlicher M, Gregor M. Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357. J Hepatol, 2005, 42: 210-217.","journal-title":"J Hepatol"},{"key":"null","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbapap.2009.11.002","volume":"1804","author":"Bogoyevitch MA","year":"2010","unstructured":"Bogoyevitch MA, Ngoei KR, Zhao TT, Yeap YY, Ng DC. c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges. Biochim Biophys Acta, 2010, 1804: 463-475.","journal-title":"Biochim Biophys Acta"},{"key":"null","doi-asserted-by":"crossref","first-page":"6924","DOI":"10.1158\/0008-5472.CAN-09-1270","volume":"69","author":"Lorin S","year":"2009","unstructured":"Lorin S, Borges A, Ribeiro Dos SL, Souquere S, Pierron G, Ryan KM, Codogno P. c-Jun NH2-terminal kinase activation is essential for DRAM-dependent induction of autophagy and apoptosis in 2-methoxyestradiol-treated Ewing sarcoma cells. Cancer Res, 2009, 69: 6924-6931.","journal-title":"Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"19245","DOI":"10.1074\/jbc.M208134200","volume":"278","author":"Mansouri A","year":"2003","unstructured":"Mansouri A, Ridgway LD, Korapati AL, Zhang Q, Tian L, Wang Y, Siddik ZH. Sustained activation of JNK\/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem, 2003, 278: 19245-19256.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3748\/wjg.v8.i6.1014","volume":"8","author":"Chen Y","year":"2002","unstructured":"Chen Y, Wu Q, Song SY, Su WJ. Activation of JNK by TPA promotes apoptosis via PKC pathway in gastric cancer cells. World J Gastroenterol, 2002, 8: 1014-1018.","journal-title":"World J Gastroenterol"},{"key":"null","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.onc.1201578","volume":"16","author":"Sanchez-Perez I","year":"1998","unstructured":"Sanchez-Perez I, Murguia JR, Perona R. Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene, 1998, 16: 533-540.","journal-title":"Oncogene"},{"key":"null","doi-asserted-by":"crossref","first-page":"21004","DOI":"10.1074\/jbc.M007592200","volume":"276","author":"Lim CP","year":"2001","unstructured":"Lim CP, Cao X. Regulation of Stat3 activation by MEK kinase 1. J Biol Chem, 2001, 276: 21004-21011.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1749-6632.2009.04911.x","volume":"1171","author":"Aggarwal BB","year":"2009","unstructured":"Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, Koca C, Dey S. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?. Ann N Y Acad Sci, 2009, 1171: 59-76.","journal-title":"Ann N Y Acad Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1074\/jbc.M210422200","volume":"278","author":"Barre B","year":"2003","unstructured":"Barre B, Avril S, Coqueret O. Opposite regulation of myc and p21waf1 transcription by STAT3 proteins. J Biol Chem, 2003, 278: 2990-2996.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcp.2006.09.012","volume":"73","author":"Tannin-Spitz T","year":"2007","unstructured":"Tannin-Spitz T, Grossman S, Dovrat S, Gottlieb HE, Bergman M. Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breast cancer cells. Biochem Pharmacol, 2007, 73: 56-67.","journal-title":"Biochem Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11060-007-9402-7","volume":"85","author":"Das CM","year":"2007","unstructured":"Das CM, Aguilera D, Vasquez H, Prasad P, Zhang M, Wolff JE, Gopalakrishnan V. Valproic acid induces p21 and topoisomerase-II (alpha\/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines. J Neurooncol, 2007, 85: 159-170.","journal-title":"J Neurooncol"},{"key":"null","first-page":"1139","volume":"13","author":"Rocchi P","year":"2005","unstructured":"Rocchi P, Tonelli R, Camerin C, Purgato S, Fronza R, Bianucci F, Guerra F. p21Waf1\/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells. Oncol Rep, 2005, 13: 1139-1144.","journal-title":"Oncol Rep"},{"key":"null","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2121-9-66","volume":"9","author":"Jung GA","year":"2008","unstructured":"Jung GA, Yoon JY, Moon BS, Yang DH, Kim HY, Lee SH, Bryja V. Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip\/WAF1 pathway. BMC Cell Biol, 2008, 9:","journal-title":"BMC Cell Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cellsig.2005.05.015","volume":"18","author":"Ahmed-Choudhury J","year":"2006","unstructured":"Ahmed-Choudhury J, Williams KT, Young LS, Adams DH, Afford SC. CD40 mediated human cholangiocyte apoptosis requires JAK2 dependent activation of STAT3 in addition to activation of JNK1\/2 and ERK1\/2. Cell Signal, 2006, 18: 456-468.","journal-title":"Cell Signal"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/47655E301AC94C1581F2132A755A4708","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmr032","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/47655E301AC94C1581F2132A755A4708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T04:28:36Z","timestamp":1686112116000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmr032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,1]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,1]]},"published-print":{"date-parts":[[2011,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmr032","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,1]]}}}